التاريخ:	--/--/-- --:--:--
مُعرِّف الحدث:	E5DOH45SG
نوع الإجراء:	ACQUISITION
حالة الإجراء:	COMPLETED
رمز سهم الشركة المستحوِذة:
الرمز المُستهدَف:	AKRO
مُحدَّث:	--/--/-- --:--:--
سعر شراء السهم:	54
عملة سعر السهم الواحد:	USD
مصادر الأخبار:	https://www.globenewswire.com/news-release/2025/12/09/3202389/0/en/Novo-Nordisk-has-completed-its-acquisition-of-Akero-Therapeutics.html

ملاحظات حول الإجراء

Novo Nordisk today announced that it has entered into a definitive agreement to acquire Akero Therapeutics, Inc. Novo Nordisk to acquire Akero Therapeutics for 54 USD per share (4.7 billion USD) in cash at closing with a contingent value right (CVR) of 6 USD per share (0.5 billion USD) The transaction has been unanimously approved by Akero's Board of Directors and is expected to close around the turn of the year, upon satisfaction of customary closing conditions including approvals by regulatory authorities. The Akero Therapeutics special shareholder meeting to vote on the transaction will be held on 12/02.